Q: We have had 10,000 shares at an avg cost of .58 cents of Medmira sitting in our portfolio for years - assuming it was pretty much a dead duck In the last few days, however, it has sprung to life quacking with an announcement of now providing C19 testing kits . I've read the news info but cannot determine if this is just a flash in the pan and we should grab the money and run. Or, is there something really here that might be a business that can bring the share price up to or past our average cost. Would appreciate your experienced eye in looking at this situation and hearing what your thoughts might be.
Many thanks as always.
Many thanks as always.
